Annual Current Liabilities
$1.18 B
+$588.14 M+99.87%
31 December 2023
Summary:
BioMarin Pharmaceutical annual total current liabilities is currently $1.18 billion, with the most recent change of +$588.14 million (+99.87%) on 31 December 2023. During the last 3 years, it has risen by +$684.48 million (+138.97%). BMRN annual current liabilities is now at all-time high.BMRN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$715.66 M
-$351.68 M-32.95%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly total current liabilities is currently $715.66 million, with the most recent change of -$351.68 million (-32.95%) on 30 September 2024. Over the past year, it has dropped by -$447.56 million (-38.48%). BMRN quarterly current liabilities is now -39.20% below its all-time high of $1.18 billion, reached on 31 December 2023.BMRN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.9% | -38.5% |
| 3 y3 years | +139.0% | +39.0% |
| 5 y5 years | +125.0% | +44.9% |
BMRN Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +139.0% | -39.2% | +54.0% |
| 5 y | 5 years | at high | +139.0% | -39.2% | +66.4% |
| alltime | all time | at high | >+9999.0% | -39.2% | >+9999.0% |
BioMarin Pharmaceutical Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $715.66 M(-32.9%) |
| June 2024 | - | $1.07 B(-1.9%) |
| Mar 2024 | - | $1.09 B(-7.6%) |
| Dec 2023 | $1.18 B(+99.9%) | $1.18 B(+1.2%) |
| Sept 2023 | - | $1.16 B(+94.8%) |
| June 2023 | - | $597.23 M(-0.2%) |
| Mar 2023 | - | $598.23 M(+1.6%) |
| Dec 2022 | $588.88 M(+7.8%) | $588.88 M(+13.0%) |
| Sept 2022 | - | $521.02 M(+12.1%) |
| June 2022 | - | $464.73 M(-5.2%) |
| Mar 2022 | - | $490.42 M(-10.3%) |
| Dec 2021 | $546.50 M(+11.0%) | $546.50 M(+6.1%) |
| Sept 2021 | - | $514.90 M(+16.1%) |
| June 2021 | - | $443.34 M(+3.1%) |
| Mar 2021 | - | $430.04 M(-12.7%) |
| Dec 2020 | $492.55 M(-47.2%) | $492.55 M(-42.4%) |
| Sept 2020 | - | $854.69 M(+5.1%) |
| June 2020 | - | $813.30 M(-0.9%) |
| Mar 2020 | - | $820.47 M(-12.0%) |
| Dec 2019 | $932.50 M(+78.2%) | $932.50 M(+88.9%) |
| Sept 2019 | - | $493.75 M(+12.4%) |
| June 2019 | - | $439.43 M(-12.3%) |
| Mar 2019 | - | $500.99 M(-4.3%) |
| Dec 2018 | $523.24 M(-35.9%) | $523.24 M(-37.6%) |
| Sept 2018 | - | $838.66 M(+4.2%) |
| June 2018 | - | $804.95 M(+4.1%) |
| Mar 2018 | - | $773.47 M(-5.3%) |
| Dec 2017 | $816.52 M(+85.9%) | $816.52 M(+95.6%) |
| Sept 2017 | - | $417.53 M(+11.5%) |
| June 2017 | - | $374.30 M(+10.0%) |
| Mar 2017 | - | $340.21 M(-22.6%) |
| Dec 2016 | $439.31 M(-1.4%) | $439.31 M(+16.4%) |
| Sept 2016 | - | $377.33 M(+3.5%) |
| June 2016 | - | $364.58 M(-6.0%) |
| Mar 2016 | - | $388.01 M(-12.9%) |
| Dec 2015 | $445.46 M(+89.0%) | $445.46 M(+14.1%) |
| Sept 2015 | - | $390.49 M(+12.3%) |
| June 2015 | - | $347.70 M(+13.8%) |
| Mar 2015 | - | $305.51 M(+29.6%) |
| Dec 2014 | $235.74 M(+28.6%) | $235.74 M(+14.1%) |
| Sept 2014 | - | $206.55 M(+23.9%) |
| June 2014 | - | $166.72 M(+6.8%) |
| Mar 2014 | - | $156.04 M(-14.9%) |
| Dec 2013 | $183.27 M(+7.5%) | $183.27 M(+9.3%) |
| Sept 2013 | - | $167.63 M(+17.9%) |
| June 2013 | - | $142.24 M(-1.2%) |
| Mar 2013 | - | $144.01 M(-15.5%) |
| Dec 2012 | $170.43 M(+81.1%) | $170.43 M(+26.3%) |
| Sept 2012 | - | $134.93 M(+12.4%) |
| June 2012 | - | $120.00 M(+0.2%) |
| Mar 2012 | - | $119.81 M(+27.3%) |
| Dec 2011 | $94.13 M | $94.13 M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $83.25 M(+1.5%) |
| June 2011 | - | $82.03 M(+8.0%) |
| Mar 2011 | - | $75.99 M(-9.4%) |
| Dec 2010 | $83.84 M(+7.3%) | $83.84 M(-9.0%) |
| Sept 2010 | - | $92.10 M(+9.7%) |
| June 2010 | - | $83.93 M(+6.6%) |
| Mar 2010 | - | $78.70 M(+0.7%) |
| Dec 2009 | $78.15 M(-39.9%) | $78.15 M(+22.0%) |
| Sept 2009 | - | $64.07 M(+6.7%) |
| June 2009 | - | $60.03 M(-52.5%) |
| Mar 2009 | - | $126.31 M(-2.9%) |
| Dec 2008 | $130.08 M(+111.4%) | $130.08 M(+7.7%) |
| Sept 2008 | - | $120.73 M(+90.4%) |
| June 2008 | - | $63.42 M(+19.0%) |
| Mar 2008 | - | $53.31 M(-13.4%) |
| Dec 2007 | $61.54 M(+33.7%) | $61.54 M(+25.4%) |
| Sept 2007 | - | $49.06 M(+10.1%) |
| June 2007 | - | $44.54 M(+14.7%) |
| Mar 2007 | - | $38.83 M(-15.7%) |
| Dec 2006 | $46.05 M(+14.1%) | $46.05 M(+6.5%) |
| Sept 2006 | - | $43.23 M(+13.7%) |
| June 2006 | - | $38.00 M(-33.2%) |
| Mar 2006 | - | $56.89 M(+40.9%) |
| Dec 2005 | $40.37 M(-42.4%) | $40.37 M(-8.7%) |
| Sept 2005 | - | $44.22 M(+1.2%) |
| June 2005 | - | $43.70 M(-13.8%) |
| Mar 2005 | - | $50.70 M(-27.6%) |
| Dec 2004 | $70.05 M(+446.7%) | $70.05 M(-7.5%) |
| Sept 2004 | - | $75.72 M(-6.8%) |
| June 2004 | - | $81.27 M(+436.0%) |
| Mar 2004 | - | $15.16 M(+18.3%) |
| Dec 2003 | $12.81 M(+87.2%) | $12.81 M(-21.1%) |
| Sept 2003 | - | $16.24 M(+6.5%) |
| June 2003 | - | $15.25 M(+19.9%) |
| Mar 2003 | - | $12.72 M(+85.8%) |
| Dec 2002 | $6.85 M(-17.5%) | $6.85 M(-18.0%) |
| Sept 2002 | - | $8.35 M(+8.0%) |
| June 2002 | - | $7.73 M(-18.1%) |
| Mar 2002 | - | $9.44 M(+13.6%) |
| Dec 2001 | $8.30 M(+20.6%) | $8.30 M(+36.3%) |
| Sept 2001 | - | $6.09 M(+18.9%) |
| June 2001 | - | $5.12 M(+40.9%) |
| Mar 2001 | - | $3.64 M(-47.2%) |
| Dec 2000 | $6.88 M(+35.3%) | $6.88 M(+90.7%) |
| Sept 2000 | - | $3.61 M(+27.7%) |
| June 2000 | - | $2.83 M(-39.6%) |
| Mar 2000 | - | $4.68 M(-8.0%) |
| Dec 1999 | $5.09 M(+154.4%) | $5.09 M(-9.2%) |
| Sept 1999 | - | $5.60 M(-29.1%) |
| June 1999 | - | $7.90 M(+393.8%) |
| Mar 1999 | - | $1.60 M |
| Dec 1998 | $2.00 M | - |
FAQ
- What is BioMarin Pharmaceutical annual total current liabilities?
- What is the all time high annual current liabilities for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual current liabilities year-on-year change?
- What is BioMarin Pharmaceutical quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly current liabilities year-on-year change?
What is BioMarin Pharmaceutical annual total current liabilities?
The current annual current liabilities of BMRN is $1.18 B
What is the all time high annual current liabilities for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total current liabilities is $1.18 B
What is BioMarin Pharmaceutical annual current liabilities year-on-year change?
Over the past year, BMRN annual total current liabilities has changed by +$588.14 M (+99.87%)
What is BioMarin Pharmaceutical quarterly total current liabilities?
The current quarterly current liabilities of BMRN is $715.66 M
What is the all time high quarterly current liabilities for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total current liabilities is $1.18 B
What is BioMarin Pharmaceutical quarterly current liabilities year-on-year change?
Over the past year, BMRN quarterly total current liabilities has changed by -$447.56 M (-38.48%)